Delivery Order SPE2DB24D2010-SPE2DB24FZTH6
- Not listed
- This federal contract award, SPE2DB22D3016|SPE2DB24FAAD1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the procurement of 4562463774 ! BRIMONIDINE-TIMOLOL 0.2%-0.5% 10ML, a pharmaceutical product, with a ceiling value of $12,157.60. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Brimonidine 0.33% Gel Pump 30GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,197.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- This federal contract award, valued at $1,022.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Brimonidine Tartrate 0.1% eye drops, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,812.02 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical eye drop product, to the Defense Logistics Agency (DLA). The $1,484.66 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,871.28 firm fixed-price delivery order is for the supply of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The award is not associated with a set-aside program and was issued as an individual delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,550.57 firm fixed-price delivery order is for the supply of 30-gram tubes of 0.33% brimonidine gel, a medication used to treat glaucoma. The contract has an ultimate completion date of July 9, 2024. Amerisourcebergen is the prime contractor and does not have any major subcontractors listed. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,323.45, is a Firm Fixed Price Delivery Order for the supply of Timolol 0.5% Gel-Solution 5ML, a medication used to treat glaucoma. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTH6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,031.10 firm fixed price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% 5ml, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC was awarded solely to AmerisourceBergen Drug Corp and does not fall under any overarching contract vehicles. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/9/24 |